Associated Papers
Biased small-molecule ligands for selective inhibition of HIV-1 cell entry via CCR5.
Berg C et al.
Pharmacology Research & Perspectives, 2016
A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands.
Swinney DC et al.
British Journal of Pharmacology, 2014
Elucidating a key anti-HIV-1 and cancer-associated axis: the structure of CCL5 (Rantes) in complex with CCR5.
Tamamis P et al.
Scientific Reports, 2014
CCR5 mutations distinguish N-terminal modifications of RANTES (CCL5) with agonist versus antagonist activity.
Choi WT et al.
Journal of Virology, 2012
Allosteric model of maraviroc binding to CC chemokine receptor 5 (CCR5).
Garcia-Perez J et al.
The Journal of Biological Chemistry, 2011
Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: insights into the mechanism of allosteric inhibition.
Maeda K et al.
Journal of Molecular Biology, 2008
Structural and molecular interactions of CCR5 inhibitors with CCR5.
Maeda K et al.
The Journal of Biological Chemistry, 2006
Select a paper to view details